share_log

UBS Maintains Buy on Aemetis, Lowers Price Target to $7.75

Benzinga ·  Aug 19 07:02  · Ratings

UBS analyst Manav Gupta maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $8.25 to $7.75.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment